Neogen Cash on Hand 2010-2025 | NEOG

Neogen cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Neogen Annual Cash on Hand
(Millions of US $)
2024 $171
2023 $246
2022 $381
2021 $381
2020 $344
2019 $268
2018 $211
2017 $144
2016 $108
2015 $114
2014 $76
2013 $85
2012 $69
2011 $56
2010 $23
2009 $14
Neogen Quarterly Cash on Hand
(Millions of US $)
2025-02-28 $128
2024-11-30 $140
2024-08-31 $120
2024-05-31 $171
2024-02-29 $168
2023-11-30 $230
2023-08-31 $239
2023-05-31 $246
2023-02-28 $183
2022-11-30 $276
2022-08-31 $348
2022-05-31 $381
2022-02-28 $378
2021-11-30 $389
2021-08-31 $401
2021-05-31 $381
2021-02-28 $353
2020-11-30 $391
2020-08-31 $367
2020-05-31 $344
2020-02-29 $328
2019-11-30 $314
2019-08-31 $291
2019-05-31 $268
2019-02-28 $247
2018-11-30 $241
2018-08-31 $226
2018-05-31 $211
2018-02-28 $192
2017-11-30 $176
2017-08-31 $160
2017-05-31 $144
2017-02-28 $125
2016-11-30 $142
2016-08-31 $129
2016-05-31 $108
2016-02-29 $125
2015-11-30 $123
2015-08-31 $111
2015-05-31 $114
2015-02-28 $102
2014-11-30 $94
2014-08-31 $88
2014-05-31 $76
2014-02-28 $69
2013-11-30 $79
2013-08-31 $84
2013-05-31 $85
2013-02-28 $75
2012-11-30 $71
2012-08-31 $75
2012-05-31 $69
2012-02-29 $61
2011-11-30 $56
2011-08-31 $51
2011-05-31 $56
2011-02-28 $48
2010-11-30 $44
2010-08-31 $34
2010-05-31 $23
2010-02-28 $31
2009-11-30 $32
2009-08-31 $24
2009-05-31 $14
2009-02-28 $14
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.103B $0.924B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.070B 28.51
Boston Scientific (BSX) United States $155.016B 38.81
Stryker (SYK) United States $151.431B 31.66
EssilorLuxottica (ESLOY) France $128.578B 0.00
Medtronic (MDT) Ireland $113.826B 16.14
Lonza Group Ag (LZAGY) Switzerland $51.396B 0.00
Haleon (HLN) United Kingdom $46.515B 26.54
ResMed (RMD) United States $37.575B 28.22
GE HealthCare Technologies (GEHC) United States $34.776B 16.51
Agilent Technologies (A) United States $34.216B 22.31
Terumo (TRUMY) Japan $26.620B 34.58
Koninklijke Philips (PHG) Netherlands $23.303B 16.35
Insulet (PODD) United States $21.112B 82.87
Zimmer Biomet Holdings (ZBH) United States $18.610B 11.95
Baxter (BAX) United States $16.026B 11.97
Smith & Nephew SNATS (SNN) United Kingdom $13.402B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.748B 23.48
Lantheus Holdings (LNTH) United States $5.495B 13.86
Prestige Consumer Healthcare (PBH) United States $3.969B 17.73
Perrigo (PRGO) Ireland $3.771B 9.56
Haemonetics (HAE) United States $3.667B 16.70
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.393B 28.20
ICU Medical (ICUI) United States $3.321B 24.49
QuidelOrtho (QDEL) United States $2.015B 13.86
LeMaitre Vascular (LMAT) United States $1.891B 42.27
AtriCure (ATRC) United States $1.594B 0.00
Acuren (TIC) United States $1.327B 0.00
AdaptHealth (AHCO) United States $1.269B 12.88
Green Thumb Industries (GTBIF) United States $1.158B 26.05
Phibro Animal Health (PAHC) United States $1.079B 13.79
BioLife Solutions (BLFS) United States $1.029B 0.00
InMode (INMD) Israel $0.937B 9.45
Kestra Medical Technologies (KMTS) United States $0.813B 0.00
Owens & Minor (OMI) United States $0.728B 6.04
CeriBell (CBLL) United States $0.671B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Evolus (EOLS) United States $0.593B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.487B 0.00
Capricor Therapeutics (CAPR) United States $0.443B 0.00
Tilray Brands (TLRY) Canada $0.424B 0.00
Surmodics (SRDX) United States $0.419B 0.00
VAREX IMAGING (VREX) United States $0.353B 12.98
Quanterix (QTRX) United States $0.334B 0.00
SNDL (SNDL) Canada $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.283B 0.00
Viemed Healthcare (VMD) United States $0.277B 23.33
Sanuwave Health (SNWV) United States $0.276B 0.00
ZimVie (ZIMV) United States $0.274B 12.46
Cresco Labs (CRLBF) United States $0.258B 0.00
Sanara MedTech (SMTI) United States $0.256B 0.00
Brainsway (BWAY) Israel $0.245B 64.88
Aurora Cannabis (ACB) Canada $0.242B 71.67
Biote (BTMD) United States $0.225B 6.34
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Verano Holdings (VRNOF) United States $0.190B 0.00
High Tide (HITI) Canada $0.187B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Organigram Global (OGI) Canada $0.177B 0.00
Omeros (OMER) United States $0.174B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.133B 16.35
Jin Medical (ZJYL) China $0.099B 0.00
Fonar (FONR) United States $0.097B 12.50
TerrAscend (TSNDF) Canada $0.091B 0.00
Veru (VERU) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Cytosorbents (CTSO) United States $0.081B 0.00
Zynex (ZYXI) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Nephros (NEPH) United States $0.043B 57.57
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.75
Safety Shot (SHOT) United States $0.033B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00